Alan G Levin insider trades
Open-market stock purchases and sales by Alan G Levin, Director at Biocryst Pharmaceuticals Inc, from SEC Form 4 filings since Feb 19, 2010.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +1%.
Companies traded
- BCRX Biocryst Pharmaceuticals Inc: 1 buy, last Jun 11, 2026
- DFFN Diffusion Pharmaceuticals Inc: other filings, last Jul 1, 2021
- ACETQ Aceto Corp: other filings, last Oct 1, 2019
- ACET Aceto Corp: 1 buy, last Dec 7, 2017
- RESX RestorGenex Corp: other filings, last Jan 8, 2016
- ENDP Endo Health Solutions Inc: 1 buy, 1 sale, last Jun 1, 2013